Back to News
Market Impact: 0.25
Legend Biotech taps Novartis veteran Zhang as CEO
Source: reuters.com
Management & GovernanceHealthcare & BiotechCompany Fundamentals
Legend Biotech appointed longtime Novartis executive Ingrid Zhang as CEO, effective immediately. The leadership change is intended to support expansion beyond Carvykti, the company’s blockbuster cancer therapy, though no financial targets or operational guidance were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
LEGN0.35
NVS0.05
More News
- ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns
- Nasdaq Nears Correction as Amazon, Alphabet, Intel Disappoint Wall Street
- Binance’s $6.3 Billion Cyber Heist Shows Crypto Vulnerabilities
- Intel’s stock crashes, knocking $12B from government’s stake
- Chevron speeds ahead in Venezuela while Exxon urges caution with a ‘little pinch of salt’
- Backbone of a beast – charting Nvidia's rise to networking titan